Cavity Margins Sample Shaving as Part of Extended Vacuum-Assisted Breast Biopsy: A Potential Approach to Predict Percutaneous Breast Cancer Excision
Authors:
- Paula ClarkePCPaula Clarke
- Eduardo Carvalho PessoaEPEduardo Carvalho Pessoa
- Bertha Andrade CoelhoBCBertha Andrade Coelho
- Daniel de Araújo Brito ButtrosDBDaniel de Araújo Brito Buttros
- Aleida Nazareth SoaresASAleida Nazareth Soares
- Bruna Torres Silvestre da SilvaBSBruna Torres Silvestre da Silva
- Hélio Rubens de Carvalho NunesHNHélio Rubens de Carvalho Nunes
- Carla Priscila Kamiya Carvalho PessoaCPCarla Priscila Kamiya Carvalho Pessoa
- Amanda Cristina Braga de OliveiraAOAmanda Cristina Braga de Oliveira
- Tereza Cristina de Oliveira FerreiraTFTereza Cristina de Oliveira Ferreira
- Bernardo Ferreira de Paula RicardoBRBernardo Ferreira de Paula Ricardo
- Paola Hartung ToppaPTPaola Hartung Toppa
Open Access
- 28 August 2026
- journal article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 33 (13) , 10918-10929
Abstract
Background: Excision of small breast cancers has been reported by vacuum-assisted biopsy (VAB). Nevertheless, patients are submitted to surgery, because there is no way to predict excision. The purpose of this study was to evaluate extended vacuum-assisted biopsy (EVAB) associated with cavity margins sample shaving (CMSH) to predict breast cancer excision. Methods: This is a retrospective database analysis of 120 cancers [both invasive breast cancers (IC) and ductal carcinoma in situ (DCIS)] diagnosed by EVAB-CMSH submitted to surgery with histological data from EVAB-CMSH and surgery. The CMSH was evaluated as a diagnostic test for excision compared to surgery as gold standard. Factors associated with residual tumor, gross residual tumor (GRD) (> 3 mm), and false-negative CMSH after EVAB-CMSH were evaluated. Results: A total of 120 cases were analyzed. Media age was 57 (48.5–69); image tumor size ( T ) was 11 (8.6–15) mm; pathological tumor size (pT) was 6 (4–10) mm; most cases IC+DCIS 53 (44.2%), DCIS 46 (38.3%), and IC 15 (12.5%); 45 (37.5%) were excised by EVAB-CMSH. CMSH sensitivity 70.7%, specificity 66.7%, false-negative rate 18.33%, and accuracy 69.2%. In multivariate analysis, DCIS pT ( p = 0.003, odds ratio [OR] 1.46, 95% confidence interval [CI]) was associated with residual tumor; DCIS pT ( p = 0.001, OR 1.34, 95% CI) and the CMSH T ( p = 0.001, OR 1.67, 95% CI) with GRD; surgical specimen DCIS T ( p = 0.015, OR 1.12, 95% CI) with CMSH false negative. Conclusions: Cavity margins sample shaving is a potential approach to predict small breast cancer excision and should be added to vacuum-assisted excision in prospective trials. For DCIS, EVAB-CMSH should not be standard of care.Keywords
This publication has 29 references indexed in Scilit:
- Improved evaluation of patients with small clusters of microcalcifications on mammograms: Implementation of vacuum assisted excision with “cavity margins shaving” techniqueEuropean Journal of Radiology, 2025
- Vacuum-assisted excision of small breast cancers under ultrasound guidanceEuropean Journal of Radiology, 2023
- Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy: current evidence and future challengesAnnals of Oncology, 2020
- The SMALL Trial: A Big Change for Small Breast CancersClinical Oncology, 2019
- Percutaneous sentinel node removal using a vacuum-assisted needle biopsy in women with breast cancer: a feasibility and acceptability studyClinical Radiology, 2019
- Omitting re-excision for focally positive margins after breast-conserving surgery does not impair disease-free and overall survivalBreast Cancer Research and Treatment, 2017
- Breast2016
- Adverse surgical outcomes in screen-detected ductal carcinoma in situ of the breastEuropean Journal of Cancer, 2014
- Impact of mammographic screening on the detection of good and poor prognosis breast cancersBreast Cancer Research and Treatment, 2011
- Rethinking Screening for Breast Cancer and Prostate CancerJAMA, 2009